Hot Topics: Clinical Questions in Schizophrenia – Question III
Dr. Christoph U. Correll will address current and relevant clinical questions relating to schizophrenia. These questions and Dr. Correll’s response will be recorded and released as short videos.
When balancing efficacy and the potential for unwanted side effects in treating schizophrenia patients, is there data regarding an optimal dose?
Christoph Correll is a paid consultant for Otsuka Pharmaceutical Development Commercialization, Inc. (OPDC)